How do you pay?

How to pay the least

Lowest posted price

$3,660 for 4 syringes

Orencia from Bristol Myers Squibb, without insurance.

What to do

  1. Sign up for BMS Patient Connect self-pay. Or call 1-800-673-6242.Sign up on bmspatientconnect.com 

Other ways

Free from the maker, if you qualify Bristol Myers Squibb Patient Assistance Foundation (BMSPAF). Or call 1-800-736-0003.

See if you qualify 

Orencia is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Compare every option

Brand name

Orencia, the original

Cash price$3,660for 4 syringes from the maker
Ways to save on Orencia

The maker’s card

ORENCIA Co-Pay Assistance Program (ORENCIA On Call)

Savings card from Bristol Myers Squibb

No insurance $3,660 for 4 syringes, from BMS Patient Connect self-pay
Insurance · as little as $5 a month

Sign up on bmspatientconnect.com 

Or call 1-800-673-6242.

In the maker’s words

“Eligible, commercially insured patients may pay as little as $5 a month for ORENCIA subcutaneous.”

“Subcutaneous Injection: 125 mg/mL (4 syringes, 1 mL each) $3,660…”

From the maker’s offer on bmspatientconnect.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Orencia is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldNone sold yet

What it’s used for

What the FDA label says

ORENCIA is a selective T cell costimulation modulator indicated for:

  • the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
  • the treatment of patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA).
  • the treatment of patients 2 years of age and older with active psoriatic arthritis (PsA).
  • the prophylaxis of acute graft versus host disease (aGVHD), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele-mismatched unrelated donor.

Limitations of Use:

Concomitant use of ORENCIA with other immunosuppressives [e.g., biologic disease-modifying antirheumatic drugs (bDMARDS), Janus kinase (JAK) inhibitors] is not recommended.

Source: the FDA label for Orencia (E.R. Squibb & Sons, L.L.C.), November 13, 2025. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.